(Q40392045)

20 September 2017

title

New multifunctional molecular conjugate vector for targeting, imaging, and therapy of tumors (English)

1 reference

20 September 2017

2

1 reference

20 September 2017

Elisabeth Garanger

1

1 reference

20 September 2017

Zhaohui Jin

3

1 reference

20 September 2017

Pascal Dumy

4

1 reference

20 September 2017

Marie-Christine Favrot

5

1 reference

20 September 2017

Jean-Luc Coll

6

1 reference

20 September 2017

language of work or name

1 reference

26 July 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

12

1 reference

20 September 2017

issue

6

1 reference

20 September 2017

page(s)

1168-1175

1 reference

Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.095

Integrins: versatility, modulation, and signaling in cell adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.095

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.095

Requirement of vascular integrin alpha v beta 3 for angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.095

In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.095

Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.095

In vitro and in vivo effects of a cyclic peptide with affinity for the alpha(nu)beta3 integrin in human melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.095

N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.095

Endothelial cells internalize and degrade RGD-modified proteins developed for tumor vasculature targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.095

Targeting of RGD-modified proteins to tumor vasculature: a pharmacokinetic and cellular distribution study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.095

RGD peptides and monoclonal antibodies, antagonists of alpha(v)-integrin, enter the cells by independent endocytic pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.095

RGD-containing peptides trigger apoptosis in glomerular mesangial cells of adult human kidneys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.095

RGD peptides induce apoptosis by direct caspase-3 activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.095

A novel RGD antagonist that targets both alphavbeta3 and alpha5beta1 induces apoptosis of angiogenic endothelial cells on type I collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.095

MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.095

Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.095

10.1016/J.YMTHE.2005.06.095

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference